Diphtheria Toxin Receptor-Targeted Brain Drug Delivery

We have collected information about Diphtheria Toxin Receptor-Targeted Brain Drug Delivery for you. Follow the links to find out details on Diphtheria Toxin Receptor-Targeted Brain Drug Delivery.


Diphtheria toxin receptor-targeted brain drug delivery ...

    https://www.sciencedirect.com/science/article/pii/S0531513105000932
    Brain drug delivery is limited by the blood–brain barrier (BBB). We have newly identified the membrane-bound precursor of heparin-binding epidermal growth factor (HB-EGF), which is also known as the diphtheria toxin receptor (DTR), as a well characterized internalizing transport receptor on the BBB for the targeting of drugs to the brain.Author: Pieter J. Gaillard, Arjen Brink, Albertus G. de Boer

Diphteria toxin receptor-targeted brain drug delivery ...

    https://www.researchgate.net/publication/229406368_Diphteria_toxin_receptor-targeted_brain_drug_delivery
    Gaillard et al. (2005) have examined the utility of CRM197, a non toxic mutant of diphtheria toxin, as a targeting vector, for drug delivery to the brain. CRM197 has been shown to endocytose after ...

Diphtheria toxin receptor-targeted brain drug delivery ...

    https://www.sciencedirect.com/science/article/abs/pii/S0531513105000932
    Brain drug delivery is limited by the blood–brain barrier (BBB). We have newly identified the membrane-bound precursor of heparin-binding epidermal growth factor (HB-EGF), which is also known as the diphtheria toxin receptor (DTR), as a well characterized internalizing transport receptor on the BBB for the targeting of drugs to the brain.Author: Pieter J. Gaillard, Arjen Brink, Albertus G. de Boer

Diphtheria toxin receptor-targeted brain drug delivery

    https://esteve.org/wp-content/uploads/2018/01/138231.pdf
    Abstract. Brain drug delivery is limited by the blood-brain barrier (BBB). We have newly identified the membrane-bound precursor of heparin-binding epidermal growth factor (HB-EGF), which is also known as the diphtheria toxin receptor (DTR), as a well characterized internalizing transport receptor on the BBB for the targeting of drugs to the brain.

Targeted Toxins in Brain Tumor Therapy

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153175/
    The successful delivery of targeted toxins directly into malignant brain tumors has established this route of administration as both practical and feasible. This review summarizes the characteristics of target toxins and the key findings of the important clinical studies with …Author: Yan Michael Li, Walter A. Hall

A novel opportunity for targeted drug delivery to the ...

    https://www.researchgate.net/publication/6121098_A_novel_opportunity_for_targeted_drug_delivery_to_the_brain
    A novel opportunity for targeted drug delivery to the brain Article in Journal of Controlled Release 116(2):e60-2 · December 2006 with 26 Reads How we measure 'reads'

EGFR-targeted diphtheria toxin stimulates TRAIL killing of ...

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3811048/
    EGFR-targeted diphtheria toxin stimulates TRAIL killing of glioblastoma cells by depleting anti-apoptotic proteins ... TRAIL or antibodies are suitable for treatment of brain tumors because they can be administered by convection enhanced delivery, which uses the blood brain barrier to confine the ... We anticipate that combining with TRAIL ...Author: Henrick Horita, Jacqueline Thorburn, Arthur E. Frankel, Andrew Thorburn

Novel approach to deliver drugs across the blood-brain ...

    http://www.lorentzcenter.nl/lc/web/2007/275/presentations/de%20boer.pdf
    Novel approach to deliver drugs across the blood-brain barrier to the brain A(Bert).G. de Boer BBB Research Group ... therefore global brain drug delivery! Alzheimer glioma (Krewson, Brain Res. 1995) ... non-toxic mutant diphtheria toxin

Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf ...

    https://link.springer.com/article/10.1023/A:1026246500788
    Oct 01, 2003 · The authors review the preclinical and clinical results of the ligand-targeted toxin conjugate Transferrin-CRM107 (Tf-CRM107), for the treatment of malignant gliomas. Tf-CRM107 is a conjugate protein of diphtheria toxin with a point mutation (CRM107) linked by a thioester bond to human transferrin (Tf). This conjugate exhibits potent cytotoxicity in vitro against mammalian cells expressing …Author: Michael Weaver, Douglas W. Laske

Brain-Targeted Drug Delivery with Surface-Modified ...

    https://link.springer.com/chapter/10.1007/978-3-030-06115-9_15
    Mar 12, 2019 · To overcome these problems, nanomedicines which are based on noninvasive strategies are an emerging trend for brain-targeted drug delivery. The advantages of nanoparticles such as small size, lipophilicity, target specificity, and controlled delivery of drug satisfy the requisites for brain targeting.Author: Sunita Lahkar, Malay K. Das

Searching for Diphtheria Toxin Receptor-Targeted Brain Drug Delivery?

You can just click the links above. The data is collected for you.

Related Delivery Info